For the Inventor, By the Inventor

Enter assignee name

Philadelphia, PA, United States of America

Ossianix, Inc.

Calculating rank

USPTO Granted Patents = 14

EPO Patents = 2

Forward Citations = 13

Loading Chart...

Loading Chart...

12 inventors (with patents filed for the assignee):

Julia Lynn Rutkowski (14 out of 14 patents)

Krzysztof Bartlomiej Wicher (9 out of 9 patents)

Pawel Stocki (8 out of 8 patents)

4. Jaroslaw Michal Szary (6 out of 6 patents)

5. Julien Häsler (5 out of 5 patents)

6. Fabrizio Comper (3 out of 3 patents)

7. Mykhaylo Demydchuk (3 out of 3 patents)

8. Aziz Gauhar (1 out of 1 patent)

9. Cyril V Privezentzev (1 out of 2 patents)

10. Julien Hasler (1 out of 1 patent)

11. Laura Thei (1 out of 1 patent)

12. Shu-Fen Coker (1 out of 1 patent)

14 patents: Sort by Forward Citations

1. 12351642 - TFR-specific binding moieties and transcytosis method to select VNARs that cross cellular barriers (2025-07-08),

2. 12297286 - Transferrin receptor (TFR)-selective binding peptides capable of crossing the blood brain barrier, encoding nucleic acids thereof and methods of use thereof (2025-05-13),

3. 12258414 - Anti-CD98hc VNARs for crossing the blood brain barrier and type IV VNAR libraries (2025-03-25),

4. 12187805 - Type-II VNAR polypeptides which bind human TfR-1, encoding nucleic acids thereof and method of use thereof (2025-01-07),

5. 11918647 - TfR selective binding compounds and related methods (2024-03-05),

6. 11766482 - In vivo methods for selecting peptides that cross the blood brain barrier, related compositions and methods of use (2023-09-26),

7. 11512136 - Transferrin receptor (TfR)-selective binding peptides capable of crossing the blood brain barrier and methods of use thereof (2022-11-29),

8. 11345742 - Shark VNARs for treating COVID-19 (2022-05-31),

9. 11339389 - Semi-synthetic nurse shark VNAR libraries for making and using selective binding compounds (2022-05-24),

10. 11267894 - BAFF selective binding compounds and related methods (2022-03-08),

11. 11097010 - In vivo methods for selecting peptides that cross the blood brain barrier, related compositions and methods of use (2021-08-24),

12. 10722576 - TfR selective binding compounds and related methods (2020-07-28),

13. 10479990 - Semi-synthetic nurse shark VNAR libraries for making and using selective binding compounds (2019-11-19),

14. 10435474 - Baff selective binding compounds and related methods (2019-10-08),

Company Overview

Ossianix, Inc. is a biotechnology company based in Philadelphia, PA, specializing in the development of innovative therapeutic solutions. The company focuses on harnessing advanced protein engineering techniques to create novel biologics aimed at addressing unmet medical needs. Ossianix is particularly known for its work in the fields of drug delivery and therapeutic proteins, leveraging its proprietary technology to enhance the efficacy and safety of treatments across various therapeutic areas.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

14 Patents

#72 in Philadelphia, PA

#803 in Pennsylvania

#22,344 in US

#42,312 in the World

Philadelphia, PA, United States of America

Ossianix, Inc.

Forward Citations = 13

12 inventors:

Julia Lynn Rutkowski (14 out of 14 patents)

Krzysztof Bartlomiej Wicher (9 out of 9 patents)

Pawel Stocki (8 out of 8 patents)

4. Jaroslaw Michal Szary (6 out of 6 patents)

5. Julien Häsler (5 out of 5 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Ossianix, Inc.. Retrieved from https://idiyas.com/company/ossianix

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…